About the Diabetes and Population Health laboratory
Our vision is to apply strong epidemiological and statistical skills to undertake novel and fundamental research to understand and describe diabetes including their causes and complications, by using multiple large datasets.
- Estimating the burden of the diabetes and obesity epidemics in Australia now and the future.
- Diabetes in developing countries.
- Diabetes and the incidence of endstage kidney disease.
- Global and country-specific rates, and trends in the incidence of diagnosed type 2 diabetes (GLOBALDIAB).
We also have a strong focus on using linkage to answer questions relating to the causes and consequences of diabetes. We have linked the National Diabetes Service Scheme (NDDS) linked to administrative databases to answer important questions about the consequences of diabetes and its interactions with other chronic diseases. Using a data-linkage model we will take a whole-of-population approach to study a range of important diabetes-related questions. Initially, we will assess the incidence of end-stage kidney disease (ESKD) among people with diabetes, and explore the link between diabetes and Alzheimer's disease (AD). Other analyses will also be possible in the future such as examining the trends and patterns of use of medications across Australia.
We have also established an international collaboration which is the first global systematic approach to ascertain whether the incidence of type 2 diabetes is falling, stabilising or increasing. The principal aims of this project are to assess country-specific rates and trends from 1995–2016 in incidence and mortality of diagnosed type 2 diabetes in adults, in both high and middle-income countries, and to quantify the relative contribution of changes in mortality and incidence on the observed prevalence. This work involves obtaining data from 28 data sources across the globe and using it to understand whether diabetes incidence and mortality is increasing, decreasing plateauing.
We are also interested in examining the environmental causes of chronic disease which ultimately will provide evidence which can guide policy around acceptable levels of environmental toxicants.